Brief: HOOKIPA Reports Fourth Quarter Results, Provides 2023 Outlook
March 15 (Reuters) - Hookipa Pharma Inc HOOK.O :
* HOOKIPA REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES 2023 OUTLOOK
* DOES NOT HOLD CASH DEPOSITS OR SECURITIES AT SILICON
VALLEY BANK
* REVENUE WAS $7.8 MILLION FOR THREE MONTHS ENDED DECEMBER
31,
2022
* QTRLY NET LOSS PER SHARE $0.17
* Q4 EARNINGS PER SHARE VIEW $-0.22, REVENUE VIEW $7.1
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX43200n
Further company coverage: HOOK.O
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)